Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cicchetti

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2024
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancerMaddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto, et al.
Frontiers in Oncology|November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancerNuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Frontiers in Oncology|November 12, 2020
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National CohortMichela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2019
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancerPetra Seibold, Adam Webb, Miguel E Aguado-Barrera, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Minerva Urology and Nephrology|January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational studyCarlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2024
Pelvic bone marrow dose-volume predictors of late lymphopenia following pelvic lymph node radiation therapy for prostate cancerMaddalena Pavarini, Lisa Alborghetti, Stefania Aimonetto, et al.
Frontiers in Oncology|November 17, 2022
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancerNuradh Joseph, Alessandro Cicchetti, Alan McWilliam, et al.
Ebiomedicine|September 21, 2022
Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohortAdam J Webb, Emily Harper, Tim Rattay, et al.
Frontiers in Oncology|November 12, 2020
A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National CohortMichela Carlotta Massi, Francesca Gasperoni, Francesca Ieva, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2019
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancerPetra Seibold, Adam Webb, Miguel E Aguado-Barrera, et al.
Pageof 4